1)  Cyanovirin-N
抗病毒蓝藻蛋白-N
1.
Objective:To construct Cyanovirin-N(CV-N) expression plasmid pET-CVN and express the protein in E.
目的:构建抗病毒蓝藻蛋白-N(Cyanovirin-N,CV-N)表达载体并在大肠杆菌中稳定表达,并进一步制备用于检测转CV-N基因表达产物的特异抗体。
2)  disease resistance
抗病
1.
Change of microflora in the rhizoplane and rhizosphere of different disease resistance soybean cultivars Ⅰ.Change of microflora in the rhizoplane and rhizosphere of soybean under normal rotation cropping condition;
抗病性不同大豆品种根面及根际微生物区系的变化 Ⅰ.非连作大豆(正茬)根面及根际微生物区系的变化
2.
Effects of Rare-earth Elements on Grouth and Disease Resistance of Animals;
稀土元素对动物生长及抗病力影响的研究
3.
Protein phosphorylation in disease resistance response of plant;
植物抗病反应中的蛋白磷酸化
3)  disease-resistant
抗病
1.
Selection of disease-resistant and high quality towel gourd variety - Baisha Xiayou 3;
抗病优质丝瓜新品种白沙夏优3号的选育
2.
Studies on the Transformation of Asiatic Lily in Disease-resistant and Senescence-inhibition;
亚洲百合‘布耐罗’抗病和抗衰老基因转化的研究
3.
High-yield and disease-resistant soybean variety Suinong 22 was bred by Suihua Agricultural Institute of Heilongjiang Academy of Agricultural Sciences through sexual crossing,which was ap- proved by Heilongjiang Crop Variety Approval Committee in 2005.
绥农22是黑龙江省农科院绥化农科所经有性杂交育成的高产抗病大豆新品种。
4)  Resistance
抗病
1.
Breeding and application of indica hybrid rice Zhanyou 226 with high yielding and resistance to blast;
高产抗病杂交稻新组合湛优226的选育
2.
This new variety has the characters of highproductivity, good quality, high resistance, anti-lodging ability etc.
该品种具有产量高、品质优、抗病、抗倒性强等优点。
5)  disease-resistance
抗病
1.
Application of Marker-assisted Selection in Disease-resistance and High-quality Wheat Breeding;
分子标记辅助选择在小麦抗病和品质遗传育种中的应用
2.
To date the majority of known plant disease-resistance genes are featured with a nucleotide-binding site (NBS) and leucine-rich repeats(LRR).
已知的植物抗病基因大多数具有核苷酸结合位点(NBS)和富含亮氨酸重复区(LRR)。
6)  antiviral agent
抗病毒剂
1.
Formulating study on a novel antiviral agent Bingduxing;
新型抗病毒剂病毒星的创制研究
参考词条
补充资料:抗Rh-D球蛋白 ,抗D人免疫球蛋白
药物名称:抗D人免疫球蛋白

英文名:

别名: 抗Rh-D球蛋白 ,抗D人免疫球蛋白
适应症: Rh阴性母亲分娩或流产Rh阳性胎儿时,胎儿红细胞中的Rh-D抗原可进入母体血液,与母体的免疫活性细胞反应,而引起异型免疫反应。本品能破坏进入母体血液的Rh-D抗原,抑制母体血液产生抗Rh(D)抗体,从而可预防Rh的异型免疫反应。
用量用法:
口服:40~60mg/日,连服4~6周,其后维持量10~20mg/日。肌注:产后3日内注射0.2g。
注意事项: 有发热、注射局部疼痛。用前应做Rh血型诊断和更精确的凝集试验。
规格: 片剂:20mg;针剂:0.2g。


类别:其他抗变态反应药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。